Correction of disease-causing CBS mutations in yeast

Mutations in cystathionine (-synthase (CBS) are known to cause homocystinuria, a recessive disorder characterized by excessive levels of total homocysteine (tHcy) in plasma¹. The primary cause of mortality is thromboembolism induced by the excessive tHcy levels. Mild increases in tHcy levels are a significant risk factor in the development of vascular disease in the general population². This can result from heterozygosity at the CBS locus or polymorphic variation in other enzymes involved in homocysteine re-methylation. We report here that a mutation which deletes the carboxy-terminal 145 amino acids of CBS can functionally suppress the phenotype of several CBS mutant alleles found in homocystinurics when expressed in yeast. This C-terminal domain of CBS acts to inhibit enzymatic activity and is in turn regulated by S-adenosylmethionine (AdoMet), a positive effector of CBS. Our results indicate that most mutations found in homocystinurics do not cause dysfunction of the catalytic domain, but rather interfere with the activation of the enzyme. These findings suggest a new drug target to treat homocystinuria and homocysteine-related vascular disease.

1. Mudd, S.H., Levy, H.L. & Skovby, F. Disorders in transsulfuration. in The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A., Sly, W. & Valle, D.) 693−734 (McG raw-Hi 11, New York, 1995).
2. Boushey, C.J., Beresford, S.A.A., Omenn, G.S. & Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease- probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274, (1995). | Article | ChemPort |
3. Kruger, W.D. & Cox, D.R. A yeast system for expression of human cystathionine beta-synthase: structural and functional conservation of the human and yeast genes. Proc.Natl. Acad. Sci. USA 91, 6614−6618 (1994). | ChemPort |
4. Gallagher, P.M. et al. High frequency of cystathionine beta-synthase mutation g307s in Irish homocystinuria patients. Hum. Mutat. 6, 177−180 (1995). | PubMed  | ISI | ChemPort |
5. Roper, M.D. & Kraus, J.P. Rat cystathionine beta-synthase: expression of four alternatively spliced isoforms in transfected cultured cells. Arch. Biochem. & Biophys. 298, 514−521 (1992). | PubMed  | ChemPort |
6. Kluijtmans, L.A. et al. Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J. Clin. Invest. 98, 285−289 (1996). | PubMed  | ISI | ChemPort |
7. Kirn, C.E. et al. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum. Mol. Genet. 6, 2213−2221 (1997). | Article | PubMed  |
8. Sherman, F. Getting started with yeast. Methods Enzymol. 194, 3−21 (1991). | Article | PubMed  | ISI | ChemPort |
9. Becker, D.M. & Guarente, L. High-efficiency transformation of yeast by electroporation. Methods Enzymol. 194, 182−187 (1991). | Article | PubMed  | ISI | ChemPort |
10. Kruger, W.D. & Cox, D.R.A yeast assay for functional detection of mutations in the human cystathionine beta-synthase gene. Hum. Mol. Genet. 4, 1155−1161 (1995). | PubMed  | ISI | ChemPort |
11. Koerner, T.J., Hill, J.E., Myers, A.M. & Tzagoloff, A. High-expression vectors with multiple cloning sites for construction of trpE fusion genes: path vectors. Methods Enzymol. 194, 477−490 (1991). | Article | PubMed  | ISI | ChemPort |
12. Harlow, E. & Lane, D., Antibodies:a Laboratory Manual, 511−552 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1998).

	Top

	Top